Medullary thyroid cancer

被引：26

作者：

Clayman, GL

El-Baradie, TS

机构：

[1] Univ Texas, MD Anderson Canc Ctr, Dept Head & Neck Surg, Houston, TX 77030 USA

[2] Natl Canc Inst, Cairo, Egypt

来源：

OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA | 2003年 / 36卷 / 01期

关键词：

D O I：

10.1016/S0030-6665(02)00136-6

中图分类号：

R76 [耳鼻咽喉科学];

学科分类号：

100213 ;

摘要：

Medullary thyroid cancer is a rare endocrine neoplasm that arises from the parafollicular C cells. Sporadic and familial (inheritable) forms of this disease exist. An emerging molecular and genetic understanding of this, neoplasm is evolving which m ay impact upon management,including screening and prophylactic treatment. Interdisciplinary evaluation and management including surgeons, endocrinologists, pathologists, radiologists, radiotherapists, and medical oncologists should be sought. Surgery remains the foundation of treatments that offer local and regional control and the potential for cure. Prognosis is variable but stage of disease and age are the main prognostic factors. Molecular genetic predictors of biologic potential remain to be established.

引用

页码：91 / +

页数：16

共 93 条

[21] Germline RET 634 mutation positive MEN 2A-related C-cell hyperplasias have genetic features consistent with intraepithelial neoplasia [J].

Diaz-Cano, SJ ;

de Miguel, M ;

Blanes, A ;

Tashjian, R ;

Wolfe, HJ .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (08) :3948-3957

[22] COMPARTMENT-ORIENTED MICRODISSECTION OF REGIONAL LYMPH-NODES IN MEDULLARY-THYROID CARCINOMA [J].

DRALLE, H ;

DAMM, I ;

SCHEUMANN, GFW ;

KOTZERKE, J ;

KUPSCH, E ;

GEERLINGS, H ;

PICHLMAYR, R .

SURGERY TODAY-THE JAPANESE JOURNAL OF SURGERY, 1994, 24 (02) :112-121

[23]

Dralle H, 1992, Henry Ford Hosp Med J, V40, P264

[24]

ENG C, 1995, ONCOGENE, V10, P509

[25] The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2 - International RET mutation consortium analysis [J].

Eng, C ;

Clayton, D ;

Schuffenecker, I ;

Lenoir, G ;

Cote, G ;

Gagel, RF ;

vanAmstel, HKP ;

Lips, CJM ;

Nishisho, I ;

Takai, SI ;

Marsh, DJ ;

Robinson, BG ;

FrankRaue, K ;

Raue, F ;

Xue, FY ;

Noll, WW ;

Romei, C ;

Pacini, F ;

Fink, M ;

Niederle, B ;

Zedenius, J ;

Nordenskjold, M ;

Komminoth, P ;

Hendy, GN ;

Gharib, H ;

Thibodeau, SN ;

Lacroix, A ;

Frilling, A ;

Ponder, BAJ ;

Mulligan, LM .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (19) :1575-1579

[26]

Evans DB, 1999, SEMIN SURG ONCOL, V16, P50

[27] Medullary thyroid cancer: The role of radiotherapy in local control [J].

Fife, KM ;

Bower, M ;

Harmer, CL .

EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 1996, 22 (06) :588-591

[28] Surgical strategy for the treatment of medullary thyroid carcinoma [J].

Fleming, JB ;

Lee, JE ;

Bouvet, M ;

Schultz, PN ;

Sherman, SI ;

Sellin, RV ;

Friend, KE ;

Burgess, MA ;

Cote, GJ ;

Gagel, RF ;

Evans, DB .

ANNALS OF SURGERY, 1999, 230 (05) :697-707

[29] Review of thyroid cancer cases among patients with previous benign thyroid disorders [J].

From, G ;

Mellemgaard, A ;

Knudsen, N ;

Jorgensen, T ;

Perrild, H .

THYROID, 2000, 10 (08) :697-700

[30]

Gilliland FD, 1997, CANCER-AM CANCER SOC, V79, P564, DOI 10.1002/(SICI)1097-0142(19970201)79:3<564::AID-CNCR20>3.0.CO

← 1 2 3 4 5 6 7 8 9 10 →